Follow
Matthieu Defrance
Matthieu Defrance
Associate Professor, Université Libre de Bruxelles
Verified email at ulb.be - Homepage
Title
Cited by
Cited by
Year
Evaluation of the Infinium Methylation 450K technology
S Dedeurwaerder, M Defrance, E Calonne, H Denis, C Sotiriou, F Fuks
Epigenomics 3 (6), 771-784, 2011
6942011
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
R Deplus, B Delatte, MK Schwinn, M Defrance, J Méndez, N Murphy, ...
The EMBO journal 32 (5), 645-655, 2013
4982013
DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients
M Volkmar, S Dedeurwaerder, DA Cunha, MN Ndlovu, M Defrance, ...
The EMBO journal 31 (6), 1405-1426, 2012
4772012
Transcriptome-wide distribution and function of RNA hydroxymethylcytosine
B Delatte, F Wang, LV Ngoc, E Collignon, E Bonvin, R Deplus, E Calonne, ...
Science 351 (6270), 282-285, 2016
3852016
RSAT: regulatory sequence analysis tools
M Thomas-Chollier, O Sand, JV Turatsinze, M Defrance, E Vervisch, ...
Nucleic acids research 36 (suppl 2), W119-W127, 2008
3372008
Using RSAT to scan genome sequences for transcription factor binding sites and cis-regulatory modules
JV Turatsinze, M Thomas-Chollier, M Defrance, J van Helden
Nature protocols 3 (10), 1578-1588, 2008
3012008
RSAT 2011: regulatory sequence analysis tools
M Thomas-Chollier, M Defrance, A Medina-Rivera, O Sand, C Herrmann, ...
Nucleic acids research 39 (suppl_2), W86-W91, 2011
2952011
RSAT 2015: regulatory sequence analysis tools
A Medina-Rivera, M Defrance, O Sand, C Herrmann, ...
Nucleic acids research 43 (W1), W50-W56, 2015
2802015
RSAT peak-motifs: motif analysis in full-size ChIP-seq datasets
M Thomas-Chollier, C Herrmann, M Defrance, O Sand, D Thieffry, ...
Nucleic acids research 40 (4), e31-e31, 2012
2672012
A comprehensive overview of Infinium HumanMethylation450 data processing
S Dedeurwaerder, M Defrance, M Bizet, E Calonne, G Bontempi, F Fuks
Briefings in bioinformatics 15 (6), 929-941, 2014
2572014
DNA methylation profiling reveals a predominant immune component in breast cancers
S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ...
EMBO molecular medicine 3 (12), 726-741, 2011
2362011
DNA methylation profiling reveals a predominant immune component in breast cancers
S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ...
EMBO molecular medicine 3 (12), 726-741, 2011
2362011
DNA methylation profiling reveals a predominant immune component in breast cancers
S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ...
EMBO molecular medicine 3 (12), 726-741, 2011
2332011
Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion
JC Larsimont, KK Youssef, A Sanchez-Danes, V Sukumaran, M Defrance, ...
Cell stem cell 17 (1), 60-73, 2015
1472015
A complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifs
M Thomas-Chollier, E Darbo, C Herrmann, M Defrance, D Thieffry, ...
Nature protocols 7 (8), 1551-1568, 2012
1262012
DNA methylation–based immune response signature improves patient diagnosis in multiple cancers
J Jeschke, M Bizet, C Desmedt, E Calonne, S Dedeurwaerder, S Garaud, ...
The Journal of clinical investigation 127 (8), 3090-3102, 2017
1252017
Portraying breast cancers with long noncoding RNAs
O Van Grembergen, M Bizet, EJ de Bony, E Calonne, P Putmans, ...
Science advances 2 (9), e1600220, 2016
1122016
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
S Uribe-Lewis, R Stark, T Carroll, MJ Dunning, M Bachman, Y Ito, L Stojic, ...
Genome biology 16, 1-15, 2015
822015
Regulation of DNA methylation patterns by CK2-mediated phosphorylation of Dnmt3a
R Deplus, L Blanchon, A Rajavelu, A Boukaba, M Defrance, J Luciani, ...
Cell reports 8 (3), 743-753, 2014
822014
Predicting transcription factor binding sites using local over-representation and comparative genomics
M Defrance, H Touzet
BMC bioinformatics 7, 1-11, 2006
812006
The system can't perform the operation now. Try again later.
Articles 1–20